NEW YORK, Jan 9 – Nanogen announced Tuesday it will post lower-than-expected fourth-quarter revenues due to lowered sales of NanoChip custom electronic microarray cartridges, but noted it had shipped 16 NanoChip molecular biology workstations during the quarter and that its losses for the fourth quarter would remain in line with Wall Street’s expectations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

The Wall Street Journal looks into the cost of new gene therapies.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.